AiP5001 RabV-CVS-N2cdeltaG-histone-EGFP
(Plasmid
#176283)
-
PurposeRecombinant rabies virus expressing histone-EGFP
-
Depositing Labs
-
Depositing OrganizationAllen Institute
Located in the United States of America -
Citations
-
Sequence Information
Ordering
| Item | Catalog # | Description | Quantity | Price (USD) | |
|---|---|---|---|---|---|
| Plasmid | 176283 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $94 | |
| DNA | 176283-D50 | 50 μg of DNA in Tris buffer | $495 | ||
| DNA | 176283-D100 | 100 μg of DNA in Tris buffer | $585 | ||
Backbone
-
Vector backboneRabies CVS N2c(deltaG)
-
Backbone manufacturerMatthias J. Schnell, Thomas Jefferson University
- Backbone size w/o insert (bp) 14061
-
Vector typeMammalian Expression
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)NEB Stable
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert nameH2B
-
SpeciesH. sapiens (human)
-
Insert Size (bp)1116
-
Entrez GeneH2BC11 (a.k.a. H2B/r, H2BFR, H2BJ, HIST1H2BJ)
-
Tag
/ Fusion Protein
- EGFP (C terminal on insert)
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site unknown (unknown if destroyed)
- 3′ cloning site unknown (unknown if destroyed)
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
Depositor Comments
Please note there are the following mutations in RabV- G1570S, R1628H, and V1630A. Depositor confirms plasmid is functional.
Please visit https://www.biorxiv.org/content/10.1101/2021.09.29.459010v1.abstract for bioRxiv preprint.
DNA (Catalog # 176283-D50)
Purpose
Ready-to-use, high-purity DNA prep. DNA aliquots are suitable for use in mammalian cell transfections and other molecular biology applications.
Delivery
- Amount 50 μg
- Concentration 1 μg/μL
- Pricing $495 USD
- Storage 4 ℃ (short-term) or -20 ℃ (long-term)
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Quality Control
Every DNA prep is verified by next-generation sequencing, confirming plasmid identity, sequence integrity, and absence of DNA contaminants. Concentration is confirmed to be within ±2.5% of the stated concentration.
Our production process has been validated to consistently yield endotoxin levels below 1.0 EU/μg. Individual lots are not tested for endotoxin.
DNA (Catalog # 176283-D100)
Purpose
Ready-to-use, high-purity DNA prep. DNA aliquots are suitable for use in mammalian cell transfections and other molecular biology applications.
Delivery
- Amount 100 μg
- Concentration 1 μg/μL
- Pricing $585 USD
- Storage 4 ℃ (short-term) or -20 ℃ (long-term)
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Quality Control
Every DNA prep is verified by next-generation sequencing, confirming plasmid identity, sequence integrity, and absence of DNA contaminants. Concentration is confirmed to be within ±2.5% of the stated concentration.
Our production process has been validated to consistently yield endotoxin levels below 1.0 EU/μg. Individual lots are not tested for endotoxin.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
AiP5001 RabV-CVS-N2cdeltaG-histone-EGFP was a gift from Allen Institute for Brain Science & Shenqin Yao (Addgene plasmid # 176283 ; http://n2t.net/addgene:176283 ; RRID:Addgene_176283) -
For your References section:
A whole-brain monosynaptic input connectome to neuron classes in mouse visual cortex. Yao S, Wang Q, Hirokawa KE, Ouellette B, Ahmed R, Bomben J, Brouner K, Casal L, Caldejon S, Cho A, Dotson NI, Daigle TL, Egdorf T, Enstrom R, Gary A, Gelfand E, Gorham M, Griffin F, Gu H, Hancock N, Howard R, Kuan L, Lambert S, Lee EK, Luviano J, Mace K, Maxwell M, Mortrud MT, Naeemi M, Nayan C, Ngo NK, Nguyen T, North K, Ransford S, Ruiz A, Seid S, Swapp J, Taormina MJ, Wakeman W, Zhou T, Nicovich PR, Williford A, Potekhina L, McGraw M, Ng L, Groblewski PA, Tasic B, Mihalas S, Harris JA, Cetin A, Zeng H. Nat Neurosci. 2023 Feb;26(2):350-364. doi: 10.1038/s41593-022-01219-x. Epub 2022 Dec 22. 10.1038/s41593-022-01219-x PubMed 36550293